Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 April 2018 Photo Johan Roux
Be an ambassador for hope - Miss Deaf SA Chantelle Pretorius
Chantelle Pretorius, Miss Deaf South Africa 2017/2018, spoke at the April graduation at the UFS Bloemfontein Campus. Spotlight photo: Rulanzen Martin

Chantelle Pretorius, Miss Deaf South Africa 2017-2018, delivered a speech filled with hope at the University of the Free State’s (UFS) Faculty of Education April graduation ceremony.

“In the words of Tata Nelson Mandela, education is the most powerful weapon you can use to change the world,” said Chantelle.
 
A journey filled with triumph 
Chantelle’s journey to becoming a UFS graduate and foundation-phase teacher at Barkly East Primary School in the Eastern Cape is an inspirational one. When she became a UFS student in 2012, she showed promise on the football field and represented the university’s first football team from 2013 to 2015. She graduated with a BA in Education in 2015.
 
“Each person will experience the journey of life differently, but when we let our light shine, we unconsciously allow others to do the same,” said Chantelle. She encouraged the graduates by reminding them there is no obstacle too big to overcome.
 
No discrimination and people-centred university
“I am honoured to stand here today, before you all, as an ambassador for hope. I have never focused on my weaknesses but rather on my strengths. I pushed myself to be a better person in life and I am thankful that I had the opportunity to obtain a degree from the UFS, even though I am a deaf person. The university does not discriminate against anybody with a disability. So I salute this institution for allowing me to make my dream of becoming a graduate come true,” said Chantelle.

Pillars of strength and inspiration

She reminded the graduates that teaching was about being a pillar of strength and inspiration to the children they will teach. Chantelle said success did not happen overnight and that the graduates would need to live life with the right approach. She encouraged them to be enthusiastic, positive and motivated teachers. “Be the teacher that touches the lives and hearts of the children you teach because in the end, it is not what you say that matters but rather how you made the child feel, that will be remembered,” she said. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept